SL STRATEGIES, LLC

Lobbying for ARGENTUM MEDICAL DBA BRAVIDA MEDICAL · leading manufacturer of antimicrobial solutions with an emphasis on hospital and surgery

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $40,000.00 income · posted Nov 10, 2025

Lobbying activity 2

Budget/Appropriations

Fiscal year 2026 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile.

Health Issues

Policies impacting rad/nuc preparedness and response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.